| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 47,631 | 28,672 | 28,111 | 8,582 |
| Accounts receivable - trade | NaN | NaN | 65 | NaN |
| Subscription receivable | NaN | NaN | NaN | 105 |
| Investments in debt securities (adjusted cost 27,156 and 0, respectively - see note 6) | 27,166 | 24,026 | 21,456 | NaN |
| Prepaid expenses and other current assets | 2,454 | 670 | 1,140 | 1,034 |
| Total current assets | 77,251 | 53,368 | 50,772 | 9,721 |
| Restricted cash | 228 | 228 | 228 | 210 |
| Promissory note receivable | 1,157 | 1,138 | 1,118 | 1,098 |
| Finance lease right-of-use assets, net of accumulated amortization | NaN | NaN | NaN | 68 |
| Operating lease right-of-use asset | 1,766 | 1,864 | 1,958 | 2,051 |
| Fixed assets, net of accumulated depreciation | 3,310 | 3,447 | 3,210 | 3,163 |
| Intangible assets, net of accumulated amortization | 1,830 | 4,338 | 6,843 | 6,848 |
| Prepaid expenses - noncurrent | 282 | NaN | NaN | NaN |
| Security deposits | 10 | 10 | 26 | 26 |
| Total assets | 85,834 | 64,393 | 64,155 | 23,185 |
| Accounts payable | 3,035 | 2,654 | 2,822 | 2,188 |
| Accrued expenses | 1,787 | 1,579 | 850 | 1,345 |
| Finance lease obligations - current portion | NaN | NaN | NaN | 53 |
| Operating lease obligation - current portion | 532 | 518 | 504 | 490 |
| Equipment financing payable - current portion | NaN | NaN | 16 | 64 |
| Term promissory note | NaN | NaN | 706 | 766 |
| Contract liabilities | 1,150 | 1,150 | 1,150 | 1,200 |
| Total current liabilities | 6,504 | 5,901 | 6,048 | 6,106 |
| Operating lease obligation - net of current portion | 1,793 | 1,932 | 2,068 | 2,199 |
| Total liabilities | 8,297 | 7,833 | 8,116 | 8,305 |
| Common stock - 0.001 par value 275,000,000 shares authorized 34,543,561 and 19,349,201 shares issued and outstanding as of march 31, 2026 and june 30, 2025, respectively | 35 | 30 | 20 | 19 |
| Additional paid-in capital | 432,190 | 403,457 | 393,978 | 347,085 |
| Accumulated other comprehensive loss | -21 | 10 | -15 | NaN |
| Accumulated deficit | -354,667 | -346,937 | -337,944 | -332,224 |
| Total stockholders' equity | 77,537 | 56,560 | 56,039 | 14,880 |
| Total liabilities and stockholders' equity | 85,834 | 64,393 | 64,155 | 23,185 |
iBio, Inc. (IBIO)
iBio, Inc. (IBIO)